Chinese university conducts trials to launch new Covid-19 drug
Category: #health  By Mateen Dalal  Date: 2020-05-21
  • share
  • Twitter
  • Facebook
  • LinkedIn

Chinese university conducts trials to launch new Covid-19 drug

Scientists at Peking University in China have successfully conducted tests for a new drug which they claim could help in containing the coronavirus pandemic. Since its outbreak in China, the disease continues to be a massive challenge for scientists and researchers across international borders.

The newly developed drug has been successful in trials at animal stage by reducing viral load in infected mice by 2,500 within a period of five days, claims Sunney Xie, Director of Peking University’s Beijing Advanced Innovation Center for Genomics. The drug uses neutralizing antibodies isolated by Xie’s team from the blood of 60 recovered patients. The team’s research study claims that the use of anti-bodies provides a possible cure for the disease and also shortens the time taken for recovery.

The development process of the drug forms part of single-cell genomics and is not based on immunology or virology, asserts Xie. He has further added that the team expects the drug to be ready for use later in the year to contain any potential outbreak.

A Chinese health official had reported last week that the country has five potential vaccines ready to be tested at the human stage.

Scientists across the world have indicated that plasma could be an effective alternative for treating coronavirus. So far, more than 700 infected people in China have undergone plasma therapy with good therapeutic effects. However, as the supply of plasma is limited, the team at Peking University has focused on 14 neutralizing antibodies that could go for immediate mass-production.

Xie has further explained that the injection of mice with neutralizing antibodies before infection with virus has restrained them from getting infected. The new drug may offer a short-term protection of a few weeks to medical workers which could hopefully be extended to a few months, says Xie.

As of now, scientists worldwide have been working upon more than 100 vaccines. The team at Peking hopes that the new drug could be faster and efficient in its efforts to contain the pandemic.

 

Source Credits:https://economictimes.indiatimes.com/news/international/world-news/scientists-in-china-believe-new-drug-can-stop-pandemic-without-vaccine/articleshow/75838236.cms

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

AstraZeneca to present results of Farxiga’s DAPA-CKD trial at ESC 2020
AstraZeneca to present results of Farxiga’s DAPA-CKD trial at ESC 2020
By Mateen Dalal

According to reliable sources, British-Swedish multinational pharmaceutical company AstraZeneca plc will present the much awaited results of the Phase III DAPA-CKD trial of Farxiga in CKD (chronic kidney disease) at ESC Congress 2020. Sources with r...

FDA grants Emergency Use Authorization to Abbott’s COVID-19 antigen
FDA grants Emergency Use Authorization to Abbott’s COVID-19 antigen
By Mateen Dalal

Abbott Laboratories, a U.S.-based medical devices and healthcare firm, has reportedly received the Emergency Use Authorization (EUA) from the U.S. FDA (Food and Drug Administration) for the detecting COVID-19 virus with its portable antigen test Bina...

Hyundai Wia Corp. signs gun parts export contract with BAE Systems
Hyundai Wia Corp. signs gun parts export contract with BAE Systems
By Mateen Dalal

Hyundai Wia Corp., a South Korea-based defense firm, has reportedly signed gun parts export contract with BAE Systems plc of worth USD 100 million via a pre-value accumulation system. As per the agreement, Hyundai Wia will supply over 106 types of gu...